HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frequency, risk factors and outcomes of retinopathy of prematurity in a tertiary care hospital in Turkey.

Abstract
The aim was to report outcomes of retinopathy of prematurity (ROP) screening conducted between March 1999 and March 2012 in a retrospective manner before October 2005 (Group 1) and prospective manner thereafter (Group 2). Data of the neonates with either a gestational age of 34 weeks or less or with a birth weight of less than 1501 g were analyzed to elucidate the frequency of ROP, ROP-related risk factors and population characteristics. Of the 640 neonates, 240 (37.5%) had any stage of ROP. Gestational age ≤32 weeks, birth weight <1500 g, oxygen therapy, respiratory distress syndrome, and sepsis were found as independent determinants for any stage of ROP. Gestational age ≤28 weeks, mechanical ventilation, intraventricular hemorrhage, and outborn infant status were found as independent determinants for treatmentrequiring severe ROP (8.6%). Frequency of ROP did not seem to follow a decreasing trend; however, neonates in Group 2 were more immature and sicker. Therefore, check-backs seem to be necessary to follow the dynamic nature of ROP.
AuthorsMurat Küçükevcilioğlu, Fatih Mehmet Mutlu, Serdar Umit Sarıcı, Osman Melih Ceylan, Halil Ibrahim Altınsoy, Selim Kılıç, Ferhat Cekmez
JournalThe Turkish journal of pediatrics (Turk J Pediatr) 2013 Sep-Oct Vol. 55 Issue 5 Pg. 467-74 ISSN: 2791-6421 [Electronic] Turkey
PMID24382525 (Publication Type: Journal Article)
Topics
  • Humans
  • Infant, Newborn
  • Retinopathy of Prematurity (epidemiology, etiology)
  • Risk Factors
  • Tertiary Care Centers
  • Turkey (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: